HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasorelaxant action of an ethylacetate fraction of Euphorbia humifusa involves NO-cGMP pathway and potassium channels.

AbstractETHNOPHARMACOLOGICAL RELEVANCE:
Euphorbia humifusa Willd. (EH) is an important traditional Chinese medicine that has commonly been used for treating bacillary dysentery and enteritis in many Asian countries for thousands of years. EH has a wide variety of pharmacological actions such as antioxidant, hypotensive, and hypolipidemic effects. However, the mechanisms involved are to be defined.
AIM OF THE STUDY:
The present study was performed to evaluate the cardiovascular effects of EH in rats.
MATERIALS AND METHODS:
Methanol extract of EH (MEH) and ethylacetate fraction of the MEH (EEH) was examined for their vascular relaxant effects in phenylephrine-precontracted aortic rings. Effects of EEH on systolic blood pressure and heart rate were tested in Sprague-Dawley rats.
RESULTS:
MEH and EEH induced vasorelaxation in a concentration-dependent manner. Endothelium-denudation abolished the EEH-induced vasorelaxation. Pretreatment of the endothelium-intact aortic rings with N(G)-nitro-L-arginine methylester (L-NAME) and 1H-[1,2,4]-oxadiazolo-[4,3-α]-quinoxalin-1-one (ODQ) significantly inhibited the EEH-induced vasorelaxation. EEH increased cGMP levels of the aortic rings in a concentration-dependent manner and the effect was blocked by L-NAME or ODQ. Extracellular Ca(2+) depletion and treatments with thapsigargin, Gd(3+), and 2-aminoethyl diphenylborinate significantly attenuated the EEH-induced vasorelaxation. Wortmannin markedly attenuated the EEH-induced vasorelaxation. In addition, tetraethylammonium, iberiotoxin, and charybdotoxin, but not apamin, attenuated the EEH-induced vasorelaxation. Glibenclamide, indomethacin, atropine, and propranolol had no effects on the EEH-induced vasorelaxation. Furthermore, EEH decreased systolic blood pressure and heart rate in a concentration-dependent manner in rats.
CONCLUSIONS:
The present study demonstrates that EEH induces endothelium-dependent vasorelaxation via eNOS-NO-cGMP signaling through the modification of intracellular Ca(2+), Ca(2+) entry, and large- and intermediate-conductance KCa channel homeostasis. The data also suggest that the Akt-eNOS pathway is involved in the EEH-induced vasorelaxation. EEH induces hypotension and bradycardia in vivo.
AuthorsTing Ting Wang, Guang Hai Zhou, Joung Hyun Kho, Yuan Yuan Sun, Jin Fu Wen, Dae Gill Kang, Ho Sub Lee, Kyung Woo Cho, Song Nan Jin
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 148 Issue 2 Pg. 655-63 (Jul 09 2013) ISSN: 1872-7573 [Electronic] Ireland
PMID23707330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Acetates
  • Plant Extracts
  • Potassium Channels
  • Receptors, Adrenergic
  • Receptors, Muscarinic
  • Vasodilator Agents
  • Nitric Oxide
  • ethyl acetate
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Prostaglandin-Endoperoxide Synthases
  • Proto-Oncogene Proteins c-akt
  • Cyclic GMP
  • Calcium
Topics
  • Acetates (chemistry)
  • Animals
  • Aorta, Thoracic (drug effects, metabolism)
  • Blood Pressure (drug effects)
  • Calcium (metabolism)
  • Cyclic GMP (metabolism)
  • Endothelium, Vascular (drug effects, metabolism)
  • Euphorbia (chemistry)
  • Heart Rate (drug effects)
  • Male
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type III (metabolism)
  • Plant Extracts (chemistry, pharmacology)
  • Potassium Channels (metabolism)
  • Prostaglandin-Endoperoxide Synthases (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic (metabolism)
  • Receptors, Muscarinic (metabolism)
  • Vasodilation (drug effects)
  • Vasodilator Agents (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: